You are invited to attend the first community engagement webinar for the 7th Global Forum on TB Vaccines (8-10 October 2024, Rio de Janeiro, Brazil).

For some forms of tuberculosis, the chances that an exposed person will get infected depend on whether the individual and the bacteria share a hometown, according to a new study comparing how different strains move through mixed populations in cosmopolitan cities.

The International Journal of Tuberculosis and Lung Disease (IJTLD) is the official publication of the International Union Against Tuberculosis and Lung Disease (The Union).

Researchers from Heinrich Heine University Düsseldorf (HHU) and the University of Duisburg-Essen (UDE) have together succeeded in identifying and synthesising a group of molecules that can act against the cause of tuberculosis in a new way. In the scientific journal Cell Chemical Biology, they describe that the so-called callyaerins act against the infectious disease by employing a fundamentally different mechanism compared to antibiotic agents used to date.

A high prevalence of tuberculosis (TB) was observed among individuals in close contact with patients infected with drug-resistant TB, indicating the need to improve TB screening efforts.

Time for $5 Campaign demands Cepheid reduce price of HIV, TB and hepatitis C tests to $5 each.

In a concerted effort to advance work towards achieving the long-term goal of eliminating TB, the World Health Organization (WHO) has initiated efforts to support countries during the validation of TB elimination, alongside establishing necessary governance structures to monitor progress.

Wayne State University, with the support of TB Europe Coalition, is conducting a research on TB and mental health in Europe and Central Asia. People who have had TB and/or have experience treating or supporting people with TB are invited to take part in an online survey available in English, French, Portuguese, Romanian, Russian, Spanish, and Ukrainian.

NEW YORK, Jul 19, 2024 – Circulating cell-free RNA (cfRNA) in blood can potentially be harnessed as a host-response biomarker for tuberculosis, according to a recent study led by Cornell University researchers.

In the battle against infectious diseases, vaccines are the most powerful allies for building immune responses. In line with this, a recent study indicates that Bacille Calmette-Guérin (BCG) boosters reveal new and existing populations of memory cells, highlighting their protective role against tuberculosis (TB) infection.